⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GSK News
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
Biodexa Licenses Phase 1 Ready Drug Candidate from Otsuka for Rare Stomach Cancer
accessnewswire.com
BDRX
GSK
PFE
NVS
COGT
BioVersys and Partners’ Phase 2a Tuberculosis Trial Results Published in New England Journal of Medicine
globenewswire.com
GSK
Monoclonal Antibodies Competitive Landscape Report 2026: Comprehensive Insights About 180+ Companies and 230+ Drugs by Company, Product, Stage of Development, Route of Administration, Molecule Type
globenewswire.com
BMY
GSK
NVS
NVO
GSK’s AREXVY Associated With Reductions in Certain RSV-Related Risks Including Heart Attack, Stroke and Severe Flare-Ups of COPD and Asthma, Real World Study Shows
businesswire.com
GSK
AGEN
GSK’s AREXVY Associated With Reductions in Certain RSV-Related Risks Including Heart Attack, Stroke and Severe Flare-Ups of COPD and Asthma, Real World Study Shows
businesswire.com
GSK
AGEN
Fallopian Tube Cancer Market Research Report 2026: AstraZeneca, GlaxoSmithKline, Pfizer and Roche Expand Portfolios and Invest in Novel Therapeutics & Companion Diagnostics - Forecasts 2025-2035
globenewswire.com
AZN
GSK
PFE
Gazyva Establishes Early Clinical Credibility in Lupus Nephritis Three Months Post-Approval, According to Spherix Global Insights
globenewswire.com
GSK
Nutricosmetics Market Poised for Strong Growth as Beauty Trends, Preventive Healthcare Focus, and Ingredient Innovation Accelerate Adoption: Verified Market Research®
prnewswire.com
PFE
GSK
JAX-NYSCF Collaborative and GSK Announce Collaboration to Advance Translational Models for Neurodegenerative Disease Research
prnewswire.com
GSK
ViiV Healthcare showcases long-acting HIV innovation and potential of ultra long-acting pipeline, including new data for first third-generation integrase inhibitor at CROI 2026
businesswire.com
PFE
GSK